Head, Translational Sciences
VeriSIM Life
Dr. Kaushik Chakravarty, Ph.D. leads external research collaborations and pursues opportunities, and defines scientific applications of the BIOiSIM platform. He works specifically in the areas of preclinical data translatability, relevant endpoints, and exhaustive review of preclinical models, leveraging our AI/ML platform for the acceleration of the drug development process for potential shortening of the timeline to IND and NDA. His research and development experience encompasses metabolic disease, physiology, in vivo pharmacology, and translational science. Dr. Chakravarty has extensive experience working with small molecules and antisense compounds. He has been in the drug discovery space for 15+ years with one of his antisense compounds completing Phase II clinical trials recently. Prior to VeriSIM Life, Chakravarty led teams at Pfizer, Roche, and NASA. He holds a Ph.D. in Nutrition and Biochemistry from Case Western Reserve University. He has published 18+ peer-reviewed scientific articles, delivered talks at several conferences, and received numerous awards for his contributions.